Latest Amiodarone Stories
NASDAQ: CRME TSX: COM VANCOUVER, Feb. 13, 2014 /PRNewswire/ - Cardiome Pharma Corp.
Atrial fibrillation (AF) is the most frequently sustained arrhythmia of the heart.
RIDGEFIELD, Conn., July 21, 2011 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) today announced that PradaxaÂ® (dabigatran etexilate mesylate) capsules has been added to hospital formularies at 49 of the top 50 cardiology and heart surgery hospitals, as ranked by U.S.
There is no difference between brand-name and generic drug formulations of amiodarone â€” taken to control arrhythmia â€“ in the incidence of thyroid dysfunction.
RIDGEFIELD, Conn., May 19, 2011 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc.
RIDGEFIELD, Conn., April 4, 2011 /PRNewswire/ -- Two new retrospective subanalyses of the RE-LY(R) trial, involving Pradaxa(R) (dabigatran etexilate mesylate) capsules, suggested that the reduction in stroke risk achieved with PRADAXA 150mg over warfarin (1) occurred irrespective of CHA2DS2-VASc risk score (2) and the type of non-valvular atrial fibrillation (NVAF) (permanent, persistent and paroxysmal)(3).
RIDGEFIELD, Conn., Feb.
RIDGEFIELD, Conn., Jan. 5, 2011 /PRNewswire/ -- Results of a post-hoc analysis of the RE-LYÂ® trial among patients with non-valvular atrial fibrillation (NVAF) undergoing cardioversion, a treatment to convert an abnormal heartbeat back to normal sinus rhythm, were published online on Jan.
- The act of sweetening by admixture of some saccharine substance.